Company · CIK 0001855175 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Contineum Therapeutics, Inc. · CTNM
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 SForm 4 → | Sep 8, 6:08 pm EDT | Carmine N. StengoneCEO and President, Director | 2,500 | $16.46 | $41,142 | 17,217 | −12.7% | 10b5-1 |
| Sep 8, 2026 MForm 4 → | Sep 8, 6:08 pm EDT | Carmine N. StengoneCEO and President, Director | 2,500 | $1.01 | $2,525 | 19,717 | — | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 MForm 4 → | Sep 8, 6:08 pm EDT | Carmine N. StengoneCEO and President, Director | 2,500 | — | — | 274,430 | — | 10b5-1 |